In May of this year, PlatformQ Health launched Medlive, combining the power of our 16 industry-leading therapeutic channels into a singular, dynamic learning platform. Representing much more than a change in name and logo, this transition reinforced our longstanding commitment to bringing innovation and connection to our learners and partners. […]
Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce that two abstracts have been accepted for presentation at the 66th ASH® Annual Meeting and Exposition taking place December 7 – 10, 2024 in San Diego. […]
The treatment of Rett Syndrome (RTT), a rare, genetic neurological disorder affecting young children that leads to severe impairments, is continuing to evolve. The first therapy was approved in March 2023, and with several investigational assets on the horizon, there is a critical need to educate both community-based clinicians and Centers of Excellence on this change to the standard of care. […]
Asthma, a serious chronic lung disease, affects 26.8 million adults and 4.5 million children in the U.S. according to the American Lung Association.1 Research on the pathophysiology of type 2 inflammation has brought new targeted therapies to market that may make a significant difference for patients affected by uncontrolled moderate-to-severe asthma.2 While these innovative biologics play a significant role in treating disease, integration by healthcare practitioners (HCPs) remains inconsistent due to barriers in provider knowledge and confidence. […]
Triple-negative breast cancer (TNBC) remains difficult to treat, and disproportionately affects women of color. To address these challenges, PlatformQ Health joined together with TOUCH: The Black Breast Cancer Alliance and the National Breast Cancer Foundation to develop a tethered educational program to empower patients in treatment decision making and to help facilitate better patient-clinical communication through sharing of real-world outcomes. […]
Early treatment of homozygous familial hypercholesterolemia (HoFH) improves outcomes for children and reduces the risk of progressive atherosclerotic cardiovascular disease. Unfortunately, the disease often goes undetected until it is in the advanced stages. […]
For people with moderate-to-severe asthma, personalization of biologic agents is warranted based on factors such as biomarkers and comorbidities. PlatformQ Health and the Asthma and Allergy Foundation of America (AAFA) conducted a CME-certified, case based, expert panel discussion that featured a live Q&A session with leading faculty from the Asthma Center at Cincinnati Children’s Hospital Medical Center and the Division of Allergy and Immunology at Northwestern University’s Feinberg School of Medicine, as well as AAFA’s public health manager. […]
PlatformQ Health is known for its outcomes-driven education. At this year’s European Conference on Rare Diseases, we co-presented two posters highlighting outcomes and lessons learned from recent programming. […]
The first FDA-approved gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD) is now available. This is a genetic disorder that presents as progressive muscle degeneration and weakness. […]
As we look forward to the holiday season, we are filled with gratitude to all our incredible partners. […]
Decades of research make clear stark disparities in asthma prevalence, mortality, and healthcare utilization along racial and ethnic lines. Black people in the United States, for example, are 1.5 times more likely to have asthma, five times more likely to visit emergency rooms for asthma attacks, and three times more likely to die from the disease. […]
PlatformQ Health, the National Organization for Rare Disorders (NORD), the International Fibrodyslpasia Ossificans Progressiva Association (IFOPA) […]
The Asthma and Allergy Foundation of America (AAFA) and PlatformQ Health have extended their long-standing collaboration for another three years to continue bringing trusted digital education to those affected by asthma and related conditions. […]
As we look forward to the holiday season, we are filled with gratitude to all our incredible partners. […]
Clinical trials are crucial for advancing care for non-Hodgkin’s lymphoma (NHL), however, accrual in these studies remains low. To address this issue, PlatformQ Health, the Leukemia & Lymphoma Society, BlackDoctor.org, and Partners for Advancing Clinical Education co-produced the BUILD-NHL Trial Equity Initiative. […]
PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. […]
Clinical trial recruitment has been a persistent problem, with studies showing up to 55% of trials are canceled prematurely due to low enrollment rates. These rates are even more dismal when it comes to diverse populations, including ethnic and racial minorities as well as seniors. Common methods for improving trial access such as transportation supports have been well documented, yet there are numerous other avenues for improving the patient experience that have yet to be uncovered. […]
Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that can influence outcomes. […]
In the wake of FDA approvals for treating myasthenia gravis (gMG, healthcare providers have the ability to individualize treatment. As these new therapies become adopted, it’s crucial to educate patients and providers about issues such as disease presentation, comorbidities, and patient preferences that may impact treatment decisions. […]
The explosion of gene and cell therapies brings promise – and a plethora of questions – from patients and healthcare providers. CAR T-cell therapy is a notable example. These one-time treatments are providing durable remission and in some cases cures of recurrent blood cancers. Due to the complexity of CAR T-cell therapy, it is currently available exclusively at specialized medical centers. […]
PlatformQ Health is excited to share that our poster session “Incorporating the Patient Voice in Rare Disease Education: Multi Stakeholder Collaborations to Improve Diagnosis, Quality of Care, and Outcomes” was selected to be presented both at the 2023 NORD Breakthrough Summit and at the Lighting Round Poster Presentations taking place from 4:30-5:00 PM on Monday, October 16. […]
Numerous posters of educational outcomes have been published at major conferences over the past three years across neuromuscular conditions, including Duchenne muscular dystrophy (DMD), myasthenia gravis (mGM), and spinal muscular atrophy (SMA). These posters highlight the advantages of aligned patient/provider education for closing knowledge gaps and aligning expectations between patients and providers. […]
It’s been a busy season here at the Q, with many educational programs launching across therapeutic areas. Thanks to partnerships with leading advocacy and membership organizations, we have been able to extend access to our trusted education to even more patients, families, and health care providers. Program Highlight We’re particularly excited to share that we’ve […]
There has been much discussion in the medical community about the imperative to improve equity in clinical trials, but what really helps when it comes to changing patient and provider perceptions? […]
Being diagnosed with macular degeneration is a shock to most patients, some of whom have no symptoms at the time. The prospect of losing some, or all of your sight can be devastating, and often leads to depression, as patients worry over the potential loss of independence and changes to their lives. […]
We’re proud to sponsor the 3rd annual Chief Patient Officer Summit, and to participate in an important conversation about improving equitable representation in clinical trials. With five years of producing digital education focused on trial diversity, we’re pleased to be able to share insights into strategies that can change behaviors and break down barriers to trial enrollment. […]
“Black women are 71% more likely to die of breast cancer than their White counterparts, so you have to question what is going on here,” she says. “Although there was knowledge in the medical community about inequities, it seemed like the default response was that this was all associated with poverty or lack of insurance, but what I found is that it’s more nuanced than that. There was bias that was contributing to these disparities. Even if a Black woman had adequate insurance and income, she was often not being presented with the standard of care.” […]
Dementia is one of the biggest global health crises of the 21st century, according to leading neurologists. More than 50 million people are living with the disease, and that number is expected to triple by 2050. Roughly 60-80 percent of dementia cases are Alzheimer’s disease. Specialists are raising awareness that neurodegeneration can begin years, and sometimes decades before a person becomes symptomatic. This is one reason early diagnosis is so crucial. […]
BOSTON AND CHICAGO, APRIL 19, 2023 – and PlatformQ Health have extended their partnership to deliver cutting-edge digital education to the urology community. […]
PlatformQ Health is pleased to announce that noted industry leader Seth Gordon has joined the organization in a senior business development and management role, supporting pharmaceutical clients seeking digital solutions to engage and educate healthcare providers and patients online. […]
Global cases of Alzheimer’s disease (AD) are expected to triple by 2050, according to a recent study presented at the Alzheimer’s Association International Conference. African American and Hispanic American communities are disproportionately affected by the disease, with African Americans having two to three times more instances and Hispanic Americans having 1.5 times more instances of […]
A pre-recorded, moderated panel discussion featuring stakeholders in CME, patient education, industry, and medical education. […]
Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Disorders (NORD) to produce digital education for health care providers (HCPs), focused on the rare dermatological condition prurigo nodularis. The 60-minute continuing medication education (CME) […]
The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on the results of recent HCP educational programs focused on Rett syndrome and Alzheimer’s disease. […]
PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array of therapeutic areas. Oncology 2022 Alliance Industry Summit Supplemental Digital Resources CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment Presenting Education Outcomes at […]
Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as antihistamine dosing. […]
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new regimens and practices. […]
As many continuing medication education (CME) program funders will tell you, finding ways to reach medical specialists is often a conundrum. Not only is their time in high demand but they have a plethora of choices when it comes to continuing education. […]
A Look Back on 2022 – Connecting patients, providers, and caregivers through education As we reflect on the past year, we are particularly grateful for the connections we made with our partners, supporters, and colleagues. These connections helped us develop meaningful patient and provider education that impacted 22 million patients. Moving the needle in healthcare […]
Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx of new clinical data and newly approved treatments, there is much education needed to ensure patients and the medical community are aware of these advances. […]
Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. […]
Patients with rare diseases are anxious to find a cure, yet roughly only half ever receive a proper diagnosis. Many of these patients return to their primary care providers (PCPs) frustrated. […]
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. […]
More than half of Americans face financial difficulties paying for medical treatment, according to a recent study. This is particularly relevant in rare diseases and cancer and exacerbates health issues while causing mounting anxiety. […]
Early diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) are key to reducing patients’ risk, yet there is low awareness of current guidelines and treatment options among healthcare practitioners. […]
Targeted therapies have allowed for better management of neuroendocrine tumors (NETs), yet this requires that healthcare providers glean new knowledge about treatment options such as somatostatin analogs. To improve provider competency and include consideration of patient perspectives in treatment selection, PlatformQ Health and Healing NET Foundation teamed up with the Moffitt Cancer Center to produce a free educational initiative for providers. […]
In the face of a rapidly shifting landscape of targeted therapies for treating gMG, PlatformQ Health, the National Organization for Rare Disorders (NORD), and the University of North Carolina at Chapel Hill collaborated to develop online CME education about the management of this disease. […]
Patients often face an epic journey of many years before receiving a diagnosis for a rare disease. With nearly one in 10 Americans impacted by a rare condition, it is essential that we decrease the time to diagnosis to improve the lives of these individuals and their families. […]
The management of developmental and epileptic encephalopathies (DEEs) has shifted in recent years, necessitating changes in treatment decisions. In the wake of these changes, PlatformQ Health, the National Organization for Rare Disorders, the Lennox Gastaut Syndrome Foundation, and the University of California, San Francisco came together to produce aligned, online continuing education to support healthcare providers in their ability to diagnose and treat DEEs and help caregivers to engage in care. […]
Ongoing clinician and public education on rare diseases is critical to raising the index of suspicion, decreasing the time to diagnosis, and providing optimal management of patients with these conditions. […]
In our latest partnership newsletter, we highlight some of our recent educational initiatives that address clinical trial equity, tethered education, strategies to improve CME outcomes and more! […]
PlatformQ Health presents a poster at the 2022 ASCO Quality Care Symposium on educational outcomes in Urothelial Carcinoma. […]
Educational outcomes from “Evolving Treatment Approaches for Generalized Myasthenia Gravis to Reduce Disease Burden and Improve Daily Living” accepted at the MGFA Scientific Session at the 2022 AANEM Conference. […]
People of color, the elderly, as well as those living in rural areas are disproportionately affected by cancer, yet are severely underrepresented in cancer clinical trials. The lack of diversity in clinical trials leaves these patients at a severe disadvantage because there is little insight into the safety and effectiveness of therapies for them. […]
When confronting a frightening condition like bladder cancer, patients may fall into a rabbit hole of information online. It can be challenging to discern what sites to trust and where to turn. Not only are patients facing concerns about their own survival, but also worries over sensitive issues such as bladder function and sexual health. In this situation, it can be difficult for patients to open up to providers about their fears. […]
Cell and gene therapies are transforming the course of disease treatment, from gene replacement that extends the lives of infants with spinal muscular atrophy, to CAR T-cell therapies that bring durable remission to patients with difficult-to-treat blood cancers. […]
Our Summer Partnership Newsletter explores some of the latest and trending medical education topics like the patient voice in CME, tethered education, the future of gene and cell therapy, improving clinical trial access, results from our recent patient survey and more! […]
Primary mitochondrial disease (PMD) is often missed by clinicians due to the broad range of clinical presentations and genetic etiologies. Our recent program “Progressive Myopathy: Could it be a Genetic Mitochondrial Disease?” focused on diagnosing this condition in infants, children, and adults who present with progressive muscle weakness; understanding the diagnostic workup; and manifestations of thymidine kinase 2 (TK2) deficiency. […]
Enhancing CME programs with patient voice is an effective strategy for helping providers retain what they’ve learned. National Organization of Rare Disorders Chief Medical and Science Officer Edward Neilan, MD, PhD noted, “when it comes to educational materials, hearing from the patient makes it much more memorable, much more engaging, and a longer lasting educational contribution.” […]
The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO Annual Meeting that demonstrate the […]
Researching clinical trials is a formidable challenge. Figuring out which trials offer the most promise to a particular patient is a monumental job, with life-altering implications. With hundreds of thousands of registered clinical trials across the country, it’s no wonder most people are overwhelmed at the prospect of it all. […]
A detailed survey of PlatformQ Health (PQH) digital education attendees found patients and families are realizing meaningful changes as a result of the learnings they gained during these programs. […]
The American Macular Degeneration Foundation (AMDF) and PlatformQ Health have forged an exclusive education partnership. Together, the organizations will deliver cutting-edge, deployable information about macular degeneration to providers, patients, and their families. […]
Carole Drexel, PhD, Medical Director & Vice President of Patient Education will present a poster at the 2022 ASGCT Annual Meeting at 5:30PM in Hall D, demonstrating the ability of digital education to improve healthcare provider (HCP) competency when preparing for a change in care delivery. […]
In collaboration with our partner network, we design education that helps clinicians understand diseases and how to communicate with their patients and empowers patients to become more active participants in their care. […]
We’re pleased to share that the conference has accepted our poster abstract “Impact of Patient-Provider Initiative on Treatment of Pediatric Neuroblastoma” at the 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. […]
May 3, 2022 – The American Society of Gene and Cell Therapy (ASGCT) has formed a strategic alliance with the digital technology and education company PlatformQ Health to deliver in-depth digital education programs for clinicians as well as patients and families. […]
The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. […]
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from diverse racial and ethnic backgrounds. […]
Together with leading advocacy organizations, we’ve created unique learning channels that help make a difference in the lives of patients with conditions such as multiple sclerosis, dementia, and many other neurological conditions. […]
PlatformQ Health is proud to be presenting three posters in Migraine, SMA and Insomnia at the American Academy of Neurology’s Annual 2022 Meeting. […]
Hear from 10-year cancer survivor, influential advocate and TOUCH CEO, Ricki Fairley, as she dispels myths around clinical trials and discusses how to drive more equitable trial enrollment. […]
In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a patient with MS who has participated in clinical trial research and Sapana Panday, Senior Director of Digital Education at PlatformQ Health. During this conversation the […]
Leaders from the Moffitt Cancer Center, NORD and TOUCH speak on behalf of their organizations about what they are doing in their day to day to make a difference in the lives of Black or other underserved patient populations. […]
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. As we enter the New Year, our CEO, Robert Rosenbloom took the time to reflect back on 2021 and impact we’ve had on patients, clinicians and caregivers. […]
As our #ASH21 blog comes to a close, the hematology community has much to look forward to with a plethora of clinically relevant data, emerging novel therapies, a better understanding of mechanisms of resistance that can lead to new therapeutic strategies, and a strong commitment from the leading hematology organization to address disparities and ensure equity. […]
Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. […]
Read a short recap of insights about day 2 of ASH, the world’s largest professional society committed to conquering blood diseases, ASH. […]
The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences. […]
As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We’re pleased to share outcomes from our digital patient education model. Download the PDF version: 2021-Infographic-Patient.pdf Be sure to check out our other End of Year Infographics: […]
Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We’re pleased to share the most significant outcomes across our CME programs and their impact on clinical practice and patient outcomes. Download the PDF version now: […]
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. […]
Tethered education: Aligning patients and providers What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? What barriers to change keep physicians from prescribing new treatments? The practice of shared decision making can help answer these crucial questions. This approach can […]
Clinicians are facing challenges with diagnosing a wide range of conditions. […]
After the CME session, 74 percent of learners reported that the activity positively impacted their clinical practice while 61 percent of learners reported that the activity positively impacted patient experiences and outcomes. […]
Through tethered education PlatformQ Health sought to address educational gaps around understanding treatment options, side effects, side of disability progression, and strategies to manage functional losses. […]
PlatformQ Health teamed up with Advances in Neuroblastoma Research Association and Solving Kids’ Cancer to develop two one-hour CME programs for clinicians, patients, and caregivers. […]
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping to reduce time to diagnosis […]
PlatformQ Health regularly tracks the outcomes of its CME courses, and publishes these to share with the medical community. […]
PlatformQ Health is presenting an outcomes poster at the American Society of Retina Specialists 39th Annual Scientific Meeting on the impact of targeted online education. […]
We would like to share some of our latest initiatives, programs, and collaborations, all made possible by our partner network. […]
New collaborations are bringing innovative approaches to patient outreach and education to address diversity in clinical trials. […]
A year-long initiative to produce rare disease digital education made a positive change on clinical practice and patient outcomes. […]
PlatformQ Health is proud to be a platinum sponsor at the 2021 Alliance Connect conference and will be sharing some of the latest insights on measuring health outcomes & accounting for social determinants of health within CPD design. […]
Some of the most important outcomes from the two-part activity highlight clinician barriers to practice in treating HER2/HER3 Metastatic Breast Cancer. […]
Abstract highlighting the impact of a new annual digital conference featuring the latest medical education from top experts on rare blood disorders, leukemias, lymphomas and rare solid tumors accepted at the 2021 ASCO Annual Meeting. […]
Stay up to date with the latest oncology research at the 2021 ASCO Annual Meeting and read more about PlatformQ Health’s educational advances in the ASCO abstract library. […]
The patient voice is the presence of the patients’ lived experiences, values, and preferences in medical education, often in the form of video testimonials. It has the power to spur real change in healthcare by capturing the attention of HCPs and inciting them to make improvements in their practice. […]
PlatformQ Health received the Best in Class award at the Alliance For Continuing Education in the Health Professions 2021 Virtual Alliance Industry Summit for the outcomes poster, “Unearthing the impact of Urology education through in-depth, qualitative interviews.” […]
An e-poster presentation on CIU education for patients, caregivers and health care providers demonstrates the impact of how virtual tethered education can close educational gaps and improve patient experience. […]
Through survey-based evaluation, the poster authors identified educational gaps that will fuel the future learning objectives and topics covered in new and upcoming educational initiatives. […]
From subject matter expertise to community engagement strategies, our partners are essential to the success of our health education programs. […]
With more opportunities than ever to reach learners online, it’s important for medical teams to evaluate how online CEs are meeting goals. […]
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations to address challenges and advances in new treatments. […]
Together, over the years, NORD and PlatformQ Health have closely collaborated to produce a multitude of digital resources for healthcare professionals, patients, and families to facilitate timely diagnosis and improved care. […]
In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. […]
While the COVID-19 pandemic has been socially and economically devastating for us all, the rare-disease community faces a unique set of challenges. Seeking to address these challenges, the National Organization for Rare Disorders (NORD) leveraged Conduit – PlatformQ Health’s proprietary engagement platform – to host the webinar, COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community. […]
PlatformQ Health is launching, “Aligned Health Care Provider and Patient Education on Calcitonin Gene-Related Peptide-Targeted Treatment of Migraine,” a new digital tethered education program, produced in collaboration with the American Migraine Foundation and the National Headache Foundation on January 22, 2021. […]
Our world will be different in 2021 and beyond. The question is, how will we, as a health education community, evolve? Here we are, finally, in 2021. For months we looked forward to turning a new year and imagined life where we are not jumping from crisis to crisis—put simply, life that just feels normal. […]
PlatformQ Health celebrates a busy end to 2020 with 15 digital programs in the month of December, including both accredited online healthcare provider activities and patient education sessions. […]
From patients to caregivers, associations to pharmaceutical companies, COVID-19 ignited transformative digital innovations across healthcare. Robert Rosenbloom, our CEO, reflects on 2020 and looks to the year ahead. […]
Under normal circumstances, managing a complicated health condition can be challenging enough with limited in-person time. Now with COVID-19, doctors are scrambling for new strategies to provide care to their patients, leading to a dramatic increase in the reliance on telemedicine. One solution gaining traction: Tethered education. […]
PlatformQ Health partnered with the American Macular Degeneration Foundation, Opthalmology360, and BroadcastMed to produce a 4-part CME activity. […]
The digital Rare Cancer Congress, held on October 28th and November 12th, engaged community-based clinicians and oncologists in 2 focused tracks on rare hematologic malignancies and rare solid tumors which encompassed 9 interactive, expert-led discussions. […]
PlatformQ Health Education is pleased to announce the publication of three of our outcomes-evaluation abstracts in conjunction with the upcoming 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. […]
PlatformQ Health and the National Organization for Rare Disorders produce 9 rare disease-focused virtual clinician education activities. […]
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. […]
Researcher, Wendy Turell, DrPH, Vice President of CME Outcomes and Analytics at PlatformQ Health Education sought to evaluate and address knowledge and competence gaps when using immunotherapies as treatment for patients with advanced Non-Small Lung Cancer (NSLCL). […]
PlatformQ Health helps long-term rare disease partner, the GBS|CIDP Foundation, transform their 2020 Summit into an interactive, engaging, virtual event. […]
With more than a decade under our belts, PlatformQ Health is the leading provider of interactive online medical education for HCPs, patients, and caregivers. We are proud to be a steady hand for our partners, panelists, supporters, and learners during uncertain times, when the demand for trusted information is so important. We are fortunate to […]
We leveraged our videobridge technology to give faculty and experts a platform to share insights from the numerous posters accepted, sharing insights from our CME and patient/caregiver activities. […]
PlatformQ Health has and will continue to collaborate with leading member organizations and patient advocacy group partners to create educational CME series that are live, sequential, interactive, and available for HCPs to watch and re-watch on-demand. […]
NORD leveraged PlatformQ Health’s digital learning platform to give their participants a convenient, user-friendly experience that would allow the rare community to connect and learn effectively, like they would have attending their in-person summit. […]
PlatformQ Health is excited to share an e-poster presentation that was accepted at the 2020 American Academy of Neurology Annual Meeting. […]
PlatformQ Health Education is proud to share that the article “Taking OAB Seriously: A Qualitative Evaluation of Primary Care Education on Overactive Bladder Syndrome Management” is available online, ahead of publication, in the Wiley journal International Journal of Clinical Practice. […]
Rare disease conference to be held online, featuring dedicated tracks patients and families and medical professionals and students. […]
PlatformQ Health is prepared for another jam-packed month of digital programs, including both accredited online healthcare provider activities and patient education sessions. […]
PlatformQ Health, the top provider of virtual healthcare events partners with Susan G Komen®, the world’s leading breast cancer organization to produce an interactive online health care provider and patient education program. […]
PlatformQ Health is thrilled to share two e-poster presentations that will be exhibited at the 80th Scientific Session of the American Diabetes Association (ADA). […]
PlatformQ Health is excited to announce an influx of upcoming June programs including both accredited online healthcare provider activities and patient education sessions produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. […]
PlatformQ Health Education is excited to present Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments, a free online CME session produced in partnership with the American Society for Preventive Cariology and accredited by the Joslin Diabetes Center (JOS). […]
PlatformQ Health is excited to share a scientific poster that showcases the results from the patient and caregiver online educational program, Positive Knowledge and Behavior Shift Following Video-Based Patient Education on Pancreatic Cancer. […]
PlatformQ Health is excited to share a poster that showcases the results from the continuing medical education (CME) program, CGRP Blockage: The Evolving Landscape of Migraine Therapy, that was accepted at the 2020 American Academy of Neurology (AAN) Annual Meeting. […]
PlatformQ Health is excited to share results from an HCP and patient education initiative that were to be presented as two uniquely focused poster presentations at the American Academy of Allergy, Asthma and Immunology’s Annual Meeting and the American Academy of Dermatology’s 2020 Annual Meeting, respectively. […]
We surveyed more than 200 HCPs to learn more about how they plan on learning in our ‘new normal’ and what information they’re seeking most often now. […]
PlatformQ Health is excited to share a poster presentation that was accepted at the Oncology Nursing Society’s 45th Annual Congress, that shares insights from three online CME programs addressing nursing care for pediatric patients with high-risk neuroblastoma. […]
PlatformQ Health is pleased to announce two new programs dedicated to updating health care professionals about telehealth and practice management, both produced in partnership with LUGPA. […]
The PlatformQ Health Team would like to extend our heartfelt gratitude today, on National Doctor’s Day, to the physicians who tirelessly dedicate themselves to the health and safety of their patients. […]
PlatformQ Health’s oncology team recognizes your need for information on practice changes to allow you, clinicians on the front line, to continue treating and protecting vulnerable patient populations. […]
2019 was a big year for PlatformQ Health. Our team is leaning in to deliver on our mission to improve health outcomes through trusted digital education, and last year it paid off, as 2019 saw: Over 100 live and on-demand educational programs More than 9 million patients impacted by our education New collaborations with best-in-class […]
February marks the beginning of a year-long, digital education initiative for HCPs and caregivers with children with pediatric epilepsy, presented in partnership with leading aligned advocacy organizations like the National Organization for Rare Disease (NORD) and Dravet Syndrome Foundation, and more. […]
We are pleased to announce a new, live video education session for families facing an amyloidosis diagnosis on NeuroCareLive. […]
PlatformQ Health is pleased to announce our team will present two sessions at the upcoming 2020 Alliance Annual Conference January 8-11th in San Francisco, CA. […]
We joined forces with the Centers for Disease Control and Prevention (CDC) to share live education for the public about the 2019-2020 influenza (flu) season, and the importance of flu vaccination. […]
Building on questions received during their first educational initiative for patients and families affected by chronic inflammatory demyelinating polyneuropathy (CIDP), PlatformQ Health and GBS|CIDP Foundation International are today pleased to announce a new video program that will be live on December 11th at 3pm ET on NeuroCareLive. […]
PlatformQ Health will present a poster session at the 2019 ASH Annual Meeting sharing insights from recent CME and patient education activities on Follicular Lymphoma. […]
How can you tell if a source of health information is trust-worthy? […]
By raising your voice through this unique campaign, you will accelerate progress for more and better options to treat depression and achieve or regain wellness. Join PlatformQ and DBSA in support of better treatment and care for depression by taking action today! […]
Learn how aligned diabetes education is moving the needle on patient care. […]
PlatformQ Health was pleased to attend the National Organization for Rare DisordersⓇ (NORD) 2019 Rare Diseases & Orphan Products Breakthrough Summit. […]
This year, the Centers for Disease Control and Prevention (CDC) is releasing two educational segments about flu vaccination with PlatformQ Health: one designed specifically for health care professionals (HCPs) and the other for members of the public. […]
The Depression and Bipolar Support Alliance (DBSA), the leading peer-directed national organization for people living with mood disorders, and PlatformQ Health, a premier provider of digital education for clinicians and patients across the therapeutic spectrum, are pleased to announce a new initiative to elevate the way clinicians diagnose and treat mental illness, and empower the millions of Americans who personally face conditions like depression and bipolar to make the best choices for their lives. […]
PlatformQ Health is pleased to be able to share outcomes from a recent patient/caregiver program on clinical trials at the ASCO Quality Care Symposium in San Diego, CA this September. […]
Following two successful programs, produced in partnership with the Carcinoid Cancer Foundation, PlatformQ Health is pleased to announce an all-new program for patients and caregivers on Neuroendocrine Tumors that will premiere live at 1pm ET on August 14, 2019 on CancerCoachLive. […]
Basal insulin is also referred to as background insulin. It is that insulin which the pancreas produces and is present all the time. […]
The National Organization for Rare Disorders (NORD)Ⓡ, the leading independent nonprofit organization representing the 25 to 30 million Americans living with rare diseases, is proud to announce it has joined forces with PlatformQ Health, a leading provider of digital education for clinicians and patients, to create accredited online education about rare diseases. Recognizing the need for accessible, engaging and effective digital education on rare diseases, NORD seeks to equip healthcare […]
PlatformQ Health is pleased to announce a three-part educational series for the clinicians treating and families facing multiple sclerosis (MS), created in collaboration with the National Multiple Sclerosis Society (NMSS) and the Consortium of Multiple Sclerosis Centers (CMSC). […]
PlatformQ Health is pleased to announce our education team will present a poster session at the 79th annual scientific session of the American Diabetes Association (ADA). […]
PlatformQ Health will be in Chicago for the 2019 ASCO Annual Meeting May 31 – June 4 and is pleased to have an abstract accepted for online publication for the 2019 meeting. […]
PlatformQ Health is pleased to announce our education team will present three poster sessions at this year’s Annual Meeting of the American Academy of Neurology (AAN), which will share insights from recent educational series in neurological diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Lennox-Gastaut Syndrome, and Multiple Sclerosis (MS). […]
We deepened relationships and developed content in new spaces with existing partners, and delivered important new clinician education in a broad variety of therapeutic areas. […]
PlatformQ Health is proud to announce a new video education program for patients with Major Depressive Disorder (MDD), which will premiere live online on March 13, 2019 at 1pm ET on NeuroCareLive.com. This latest collaboration with the Depression and Bipolar Support Alliance (DBSA) follows a successful program last year that featured real patient testimonials, and an expert panel including clinicians and advocacy representatives. […]
On Rare Disease Day 2019, we acknowledge the realities of daily life for people around the world who are managing a rare disease. […]
Join our experts for a one-hour CME presentation as they appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis. […]
Going to see your doctor can be a frightening experience: you may be worried you have a serious affliction, or maybe you’re just going to follow up for a chronic condition, or maybe there is a procedure you are facing that you know will be painful. […]
According to the CDC, ovarian cancer is the second most common gynecologic cancer, comprising 3% of all cancers in women. Approximately 11 out of every 100,000 women are diagnosed with new cases annually (over 20,000), and 7 out of every 100,000 (over 14,000) will die of the disease in the same time period. […]
November is National Diabetes Month and PlatformQ Health is excited to support the awareness and empowerment of patients and caregivers managing diabetes by providing them with interactive education. […]
Overactive bladder (OAB) is a distressing bladder disorder marked by urinary urgency, frequency, nocturia, and urge incontinence. It often has a negative impact on the quality of life, sleep, sexual function, and mental health. […]
PlatformQ Health is pleased to support the “Well Beyond Blue” initiative, championed by the Depression and Bipolar Support Alliance (DBSA), which aims to connect people who live with depression with researchers, regulators, and life science companies better understand what it’s like to live with depression and what is most important in terms of better treatment options. […]
The 2018 ASCO Quality Care Symposium was held on September 28 and 29, 2018 in Phoenix, AZ, and PlatformQ Health was honored to present a poster session on the impact of online patient education for people with bladder cancer. […]
A new follicular lymphoma CME program worth 1 AMA PRA Category 1 Credits™, is now available on demand. Find it here. In the Western hemisphere, follicular lymphoma (FL) is the most common non-Hodgkin lymphoma (NHL). In the US in 2018, it is expected that approximately 74,680 new cases of NHL will be diagnosed and 20% […]
Current statistics estimate that this year, of the 1,735,350 new cases of cancer that will be diagnosed in the United States, over 1.1 million people will face the challenges of continuing to live a meaningful life with cancer. While everyone has heard about the rigors of and side effects than can accompany cancer treatments such […]
Find new Idiopathic Pulmonary Fibrosis CME on ResInsightsLive, and a program designed for patients and their families on RareDiseaseLive. Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease caused by the formation of scar tissue in the lungs without any known triggering factor. Across the globe, five million people are affected with a prevalence […]
You’ve just seen your doctor and they told you that you have a chronic disease, or you’ve been struggling with one (or more) for years now. You may be overwhelmed with the amount of information your doctor gave you about your new disease, or maybe you weren’t given any at all. The doctor may have […]
Our commitment to oncology practice and cancer care makes ASCO 2018 one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through trusted digital education for people with cancer. […]
He lay there in the ICU bed with his family standing by in the waiting area. As the intern on call, I was called to his bedside once again because his blood pressure plunged dangerously low. Unfortunately, his prognosis was poor, in fact terminal. The medical team knew this would be the last time he […]
Jeff Arnold, General Manager at PlatformQ Health, attended the latest meeting of the American Urological Association (AUA) in San Francisco. […]
On Wednesday, May 9, 2018 from 11:00 AM – 12:00 PM ET, a diabetes CME program about new long acting insulins for the treatment of Type 2 Diabetes will air live on DiabetesSeriesLive. New Long-acting Insulins for the Treatment of Type 2 Diabetes: Data, Guidelines, and Perspectives on Patient and Provider Barriers will cover: • […]
Multiple sclerosis (MS) is a complicated demyelinating disease of the central nervous system, where patients experience a great range of symptoms due to demyelination of nerve fibers. It is characterized by plaques in the brain and spinal fluid. Symptoms that have been observed include numbness, diplopia, cognitive impairment, paralysis, blindness, fatigue, and bladder dystonia. [1] […]
PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology (AAN). Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. […]
The Spring session of CMEpalooza featured two full days of live programming designed for the continuing medical education community. This year, PlatformQ Health (PQH) sent two delegates to the session titled Including Patients and Patient Advocacy Groups in Educational Planning & Delivery: How to Make It a “Win-Win”. Senior VP of Education, Kathryn Pucci, acted […]
PlatformQ Health is pleased to announce the Health Education Journal, a peer reviewed journal focusing on the contributions that health education can make to personal and social well-being, health promotion and individual and public health, has published an article on a recent Platform Q Patient Education (PQPE) program for people with B-cell NHL. […]
PlatformQ Health will present a poster at the Alliance Industry Summit (AIS) 2018 “Best in Class Outcomes Awards” Monday, May 7, 2018 highlighting a series of diabetes programs for clinicians created in collaboration with the renowned Joslin Diabetes Center. […]
Most patients with diabetes end up with a glucometer for testing their blood sugar at home. However, I frequently find that many of the patients I see did not receive instructions on how or when to check their sugar, or what to do with the results when they have them. Of course, the answer to […]
PlatformQ Health is pleased to announce our education team will present two poster sessions at the 2018 Annual Meeting of the American Academy of Neurology April 23 and 24 in Los Angeles, California. […]
Currently, the guidelines around prostate cancer for physicians like me follow are murky, and best practices are subject to debate by different medical organizations. A widely-known recommendation called a PSA (Prostate Specific Antigen) screening, for example, has been fraught with failings and blamed for causing an unacceptable number of unnecessary prostate biopsies. On March 19, […]
March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often […]
While much research is being conducted into rising rates of diabetes mellitus around the globe, in the US an approximate 85 million people have prediabetes. Prediabetes is a condition where a person’s blood sugar is elevated outside the normal range but do not meet the criteria for diabetes. It is very important to identify these […]
What do doctors need to know about prostate cancer and the tests used to diagnose it? According to the American Cancer Society, who offer the most recent data regarding cancer statistics in the U.S., an estimated 161,360 men were newly diagnosed with prostate cancer in 2017. In the same time period, over 26,000 men died […]
Log into PainCareLive on Tuesday, March 13, 2018 at 2:00 PM ET for a live online CME Certified activity discussing the safety, efficacy, and tolerability profiles of abuse-deterrent opioid formulations and their potential to reduce opioid misuse/abuse in treating patients with acute or chronic pain. This accredited program, Targeting Opioid Misuse: Abuse-Deterrent Formulations in the Management […]
Please join DiabetesCoachLive for a special program designed for diabetic people and their loved ones. Patients and experts from Joslin Diabetes Center will be walking through insulin options, debunking myths about side effects, and answering questions from the audience. Watch on demand now >> When people think of diabetes, their mind immediately jumps to […]
Today, medical school enrollment is nearly equivalent between men and women across the country – but most women physicians still believe that disparities exist between male and female doctors due to personal experience and staggering gender differences in medical leadership. While 73 percent of health service and medical manager jobs are held by women, only […]
World Rare Disease Day is celebrated on the last day of February each year (often February 28, “rarely” on leap day). Since 2008, this day has grown into a global initiative involving more than 90 countries and hundreds of cities to raise awareness of rare diseases and encourage researchers and leaders to address the needs […]
The biggest yearly gathering in CME, the Alliance Annual Conference, just wrapped up in Orlando, Florida, after several engaging days of programming around the theme Destination: Patient Outcomes. Our Journey to Improving Patient Care. Several members of the PlatformQ Health Education (PQH Education) leadership team were in attendance, and we were happy to be able […]
On February 9, 2018 at 10:00 am EST, join CardioCareLive for a roundtable discussion on the new guidelines for the treatment of heart failure. In this second part of our series on Implementing Guideline-Directed Medical Therapy for Patients with Heart Failure, the panelists will discuss multidisciplinary approaches to implementing the guidelines – specifically, the challenges […]
February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA) […]
PlatformQ Health Education (PQH Education) was proud to send several delegates to the 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida. The Alliance Annual Conference is the largest gathering in CME, and this year’s theme was Destination: Patient Outcomes. Our Journey to Improving Patient Care. In addition to presenting two sessions and […]
Schizophrenia is a mental health disorder that is chronic and disabling and affects the way a person thinks, feels, and behaves. Typically, symptoms start between the ages of 16 and 30; rarely it is observed in children as well. Symptoms of this disease are categorized into 3 types – positive, negative, and cognitive: Positive symptoms: These […]
PlatformQ Health Education, in joint providership with the American Academy of Family Physicians (AAFP), announces the first of two online educational programs on shared decision making in major depressive disorder (MDD) treatment. Major depressive disorder (MDD) has substantial negative effects on patients’ functional abilities and quality of life. This tethered, or mutual, education will focus […]
Please join us in congratulating Wendy Turell as she receives an Alliance Leadership Award in recognition of her service and direction as Chair of the Alliance Research Committee. The Opening Night Awards Dinner will take place January 20th from 5:30 – 7:30pm, kicking off the annual conference with a celebration of the education industry and […]
The inaugural program for CancerCoachLive, PlatformQ Health’s educational channel for online patient education about different forms of cancer, was launched in 2016 through a partnership with The Leukemia & Lymphoma Society (LLS) focusing on educating patients with B-cell non-Hodgkin lymphomas (NHL). Building on LLS’s goal to empower patients through education, this program aimed to improve knowledge […]
PlatformQ Health Education (PQH Education) is pleased to announce we will be presenting two sessions at the upcoming 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida. The Alliance Annual Conference is the largest gathering in CME, bringing together professionals in continuing healthcare education from across the spectrum of organization settings. These […]
Healthcare professionals and policymakers are struggling to come to terms with the epidemic of opioid abuse and overdose in the United States – perhaps nowhere more than here in Massachusetts, where the presence of premier medical institutions has not been able to stem the state’s record high rates of opioid-overdose deaths (which are among the […]